Expression of zebrafish Lc3 synthase gene in embryonic lens requires hedgehog signaling.

Dev Dyn

Department of Biological Sciences and Biotechnology, Protein Sciences Laboratory of the MOE, Tsinghua University, Beijing, China.

Published: November 2003

Glycosyltransferases are involved in synthesis of various glycolipids and glycoproteins that play important roles in many biological processes. We have identified a zebrafish gene encoding a member of beta1,3-N-acetylglucosaminyltransferase family, the Lc3 synthase/bGn-T5. Whole-mount in situ hybridization reveals that the Lc3 synthase gene is expressed in two distinct phases during the zebrafish embryogenesis. The early phase extends from late blastulation to the completion of epiboly, during which the expression occurs in the superficial layer of the embryos. The second phase of expression starts during mid-segmentation and persists until day 3, during which the expression occurs prominently in the developing lens. The expression of the Lc3 synthase gene in the lens is inhibited in you-too (yot) mutant embryos that are defective in Hedgehog signaling. The expression in the lens also decreases in cyclops (cyc) and one-eyed-pinhead (oep) mutant embryos and lefty1-injected embryos, which are deficient in Nodal signaling and lack Hedgehog activity in the ventral brain. These results suggest that Hedgehog signaling is required for the Lc3 synthase expression in embryonic lens.

Download full-text PDF

Source
http://dx.doi.org/10.1002/dvdy.10372DOI Listing

Publication Analysis

Top Keywords

lc3 synthase
16
synthase gene
12
hedgehog signaling
12
embryonic lens
8
expression occurs
8
mutant embryos
8
expression
7
lc3
5
lens
5
expression zebrafish
4

Similar Publications

Baicalein tethers CD274/PD-L1 for autophagic degradation to boost antitumor immunity.

Autophagy

December 2024

Institute of Energy Metabolism and Health, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.

Immune checkpoint inhibitors, especially those targeting CD274/PD-L1yield powerful clinical therapeutic efficacy. Thoughmuch progress has been made in the development of antibody-basedCD274 drugs, chemical compounds applied for CD274degradation remain largely unavailable. Herein,baicalein, a monomer of traditional Chinese medicine, isscreened and validated to target CD274 and induces itsmacroautophagic/autophagic degradation.

View Article and Find Full Text PDF

eEF2K alleviates doxorubicin-induced cardiotoxicity by inhibiting GSK3β and improving autophagy dysfunction.

Cell Biol Toxicol

December 2024

Department of Cardiology, Laboratory of Heart Center, Zhujiang Hospital, Southern Medical University, No 253, Middle Gongye Avenue, 510282, Guangzhou, Guangdong, People's Republic of China.

Doxorubicin-induced cardiotoxicity (DIC) poses a threat to the health and prognosis of cancer patients. It is important to find a safe and effective method for the prevention and treatment of DIC. eEF2K, which is a highly conserved α-kinase, is thought to be a therapeutic target for several human diseases.

View Article and Find Full Text PDF

Inhibiting UGCG prevents PRV infection by decreasing lysosome-associated autophage.

Int J Biol Macromol

January 2025

School of Food and Bioengineering, Henan University of Animal Husbandry and Economy, Zhengzhou, Henan Province, People's Republic of China, Zhengzhou 450046, China. Electronic address:

Glucosylceramide synthase (UGCG) is a key enzyme that catalyzes the initial glycosylation step in the biosynthesis of glycosphingolipids (GSLs) derived from glucosylceramide. UGCG is closely associated with various cellular processes, including the cell cycle, angiogenesis, multidrug resistance, and pathogen invasion. In this study, a short hairpin RNA (shRNA) library designed to target key genes involved in the sphingolipid metabolic pathway was utilized to elucidate their roles in Pseudorabies Virus (PRV).

View Article and Find Full Text PDF

A combined treatment with Ursolic acid and Solasodine inhibits colorectal cancer progression through the AKT1/ERK1/2-GSK-3β-β-catenin axis.

Phytomedicine

December 2024

School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang 110016, PR China; Key Laboratory of Pharmacodynamic Substances Research & Translational Medicine of Immune Diseases of Shenyang, Shenyang Pharmaceutical University, Shenyang 110016, PR China; Key Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, PR China. Electronic address:

Article Synopsis
  • Conventional chemotherapy struggles with drug resistance and side effects in colorectal cancer (CRC), prompting research into natural compounds like Ursolic acid (UA) and Solasodine (Sol) that show promise in anti-tumor activity.
  • This study focused on the synergy between UA and Sol in fighting CRC by triggering cell death (apoptosis) and preventing the spread (metastasis) of cancer through specific cellular pathways.
  • Results indicated that combining UA and Sol effectively reduced CRC cell viability and promoted cancer cell death by enhancing gene expression related to apoptosis and autophagy, while also inhibiting factors that facilitate cancer spread.
View Article and Find Full Text PDF

VCP enhances autophagy-related osteosarcoma progression by recruiting USP2 to inhibit ubiquitination and degradation of FASN.

Cell Death Dis

November 2024

Department of Orthopedic Surgery, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, 330006, People's Republic of China.

Osteosarcoma (OS) is a highly aggressive malignant tumor with a high rate of disability and mortality rates, and dysregulated autophagy is a crucial factor in cancer. However, the molecular mechanisms that regulate autophagy in OS remain unclear. This study aimed to explore key molecules that affect autophagy in OS and their regulatory mechanisms.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!